Evidence map›Paper›PMID 31087195›Full record

ReviewJournal of neural transmission (Vienna, Austria : 1996)2019

Dyskinesia in multiple system atrophy and progressive supranuclear palsy.

Wolfgang H Jost, Paul Lingor, Lars Tönges, Johannes Schwarz, Carsten Buhmann, Jan Kassubek, Anette Schrag

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of neural transmission (Vienna, Austria : 1996), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Types of Pain in Multiple System Atrophy.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  3. Article
  4. Article
  5. Status of Current Biofluid Biomarkers in Parkinson's Disease.Movement disorders clinical practice · 2023
    Article
  6. Article
  7. Early suspicion of progressive supranuclear palsy using dopamine transporter imaging: an illustrative case presenting with levodopa-responsive parkinsonism.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wolfgang H JostParkinson-Klinik Ortenau, Kreuzbergstr. 12, 77709, Wolfach, Germany. W.Jost@parkinson-klinik.de.ORCID 0000-0002-8574-3297
Paul LingorKlinik für Neurologie, Klinikum Rechts der Isar der TU München, Munich, Germany.
Lars TöngesDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
Johannes SchwarzDepartment of Neurology, Klinik Haag i. OB, Oberbayern, Germany.
Carsten BuhmannDepartment of Neurology, University Clinic Eppendorf, Hamburg, Germany.
Jan KassubekDepartment of Neurology, University of Ulm, Ulm, Germany.
Anette SchragUCL Institute of Neurology, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the differential diagnosis of Parkinson syndromes, the response to L-Dopa is an essential criterion for the diagnosis of idiopathic Parkinson's syndrome (IPS), and the presence of L-Dopa-induced dyskinesia (LID) is considered a supportive criterion. This implies that in the presence of LID an atypical Parkinson-syndrome (APS) is unlikely. However, dyskinesia, and in particular LID, can also be present in APS such as MSA and PSP, although less frequently, and with varying clinical appearance. We conclude that whilst presence of dyskinesia provides support for a diagnosis of IPD, they do not allow reliable differentiation from APS.

Indexed as

Diagnosis, DifferentialDyskinesia, Drug-InducedDyskinesiasHumansLevodopaMultiple System AtrophyParkinson DiseaseSupranuclear Palsy, ProgressiveLevodopaDyskinesiaMultiple system atrophyParkinson’s diseaseProgressive supranuclear palsy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.